Fig. 3.
Cytotoxicity against HLA-class I-matched cancer cells. Pre- and post-vaccination peripheral blood mononuclear cells (PBMCs) were cultured with interleukin-2 and the corresponding peptide for 14 days. The cytotoxicity of cultured PBMCs against Colo201 (HLA-A2+ colon carcinoma), SW620 (HLA-A2- and -A24+ colon carcinoma), Colo320 (HLA-A24+ colon carcinoma), and phytohemagglutinin (PHA)-blastoid T cells (HLA-A2+ or HLA-A24+) was measured